Exercise for High Blood Sugar During Pregnancy
(TtM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how exercise timing affects blood sugar levels, sleep, and mood in pregnant individuals with high blood sugar issues, such as gestational diabetes. Participants will engage in 30 minutes of moderate exercise, like walking, either in the morning or late afternoon/evening, to determine if timing influences outcomes. It suits those pregnant with one baby and diagnosed with gestational diabetes or glucose intolerance. The goal is to discover if exercising at different times of the day can better manage these conditions. As an unphased trial, this study allows participants to contribute to valuable research that could enhance health recommendations for pregnant individuals with gestational diabetes.
Will I have to stop taking my current medications?
The trial requires that participants not be on daily medications that alter insulin resistance or metabolic profiles, such as metformin, corticosteroids, or anti-psychotics. If you are taking these medications, you would need to stop them to participate.
What prior data suggests that this exercise protocol is safe for pregnant individuals?
Research shows that walking at a moderate pace is well-tolerated by people with gestational diabetes (GDM). Studies have found that this type of exercise helps control blood sugar and is safe for pregnant individuals. For instance, walking every day effectively manages GDM without causing negative effects. Another study found that aerobic exercise like walking improved blood sugar levels and pregnancy outcomes. Overall, the evidence indicates that moderate walking is a safe and helpful way to manage high blood sugar during pregnancy.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the timing of physical activity as a way to manage high blood sugar during pregnancy, also known as gestational diabetes. Unlike standard treatments like dietary changes, insulin, or oral medications, this approach investigates whether exercising at specific times of the day can make a difference in blood sugar control. The trial compares moderate-intensity walking or stepping either in the morning or the late afternoon/evening. By understanding the impact of exercise timing, researchers hope to offer a simple, non-invasive strategy that could complement existing treatments and improve outcomes for pregnant individuals.
What evidence suggests that this trial's physical activity timing could be effective for managing high blood sugar during pregnancy?
Research has shown that moderate exercise, such as walking, can help manage blood sugar levels in pregnant women with gestational diabetes or glucose intolerance. This trial will compare two different timing strategies for exercise: one group will perform moderate-intensity walking or stepping in the morning, while another group will do the same in the afternoon or evening. Specifically, one study found that this type of exercise improves blood sugar levels after meals and overall blood sugar control. Walking daily has proven effective in maintaining steady blood sugar levels for those with gestational diabetes. Another study demonstrated that just 20 minutes of walking after eating can lower blood sugar in these women. Overall, exercise offers a promising method to help control blood sugar during pregnancy.678910
Who Is on the Research Team?
Samantha Ehrlich, PhD
Principal Investigator
The University of Tennessee, Knoxville
Are You a Good Fit for This Trial?
This trial is for pregnant individuals aged 18-40 with gestational diabetes or glucose intolerance, carrying a single baby without significant abnormalities. Participants must have been diagnosed after 24 weeks of pregnancy and be comfortable communicating in English without a translator.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a randomized crossover trial involving 30 minutes of moderate intensity walking or stepping at specified times over an 11-day period.
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Moderate intensity walking or stepping
Trial Overview
The study tests the effects of timing on physical activity—specifically, whether walking or stepping for 30 minutes in the morning versus late afternoon/evening has different impacts on blood sugar levels, sleep quality, and mood during pregnancy.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Randomized to complete 30 minute of moderate intensity walking or stepping in the morning (i.e., between 5am-9am, within 30-40 minutes of starting breakfast) on days 4 and 5, and 30 minute of moderate intensity walking or stepping in the late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on days 9 and 10.
Randomized to complete 30 minute of moderate intensity walking or stepping in the late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on days 4 and 5, and 30 minute of moderate intensity walking or stepping in the morning (i.e., between 5am-9am, within 30-40 minutes of starting breakfast) on days 9 and 10.
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
University of Tennessee Graduate School of Medicine
Collaborator
Published Research Related to This Trial
Citations
Physical activity for blood glucose control in gestational ...
The authors reported an improvement in postprandial glucose and glycated hemoglobin in response to moderate intensity walking with exercise ...
Exercise Intervention Improves Blood Glucose Levels and ...
Daily walking is effective for the management of pregnant women with gestational diabetes mellitus. The Journal of Obstetrics and Gynaecology Research .
Exercise for High Blood Sugar During Pregnancy (TtM Trial)
Research shows that moderate-intensity exercise, like walking or stepping, can help manage blood sugar levels in pregnant women with gestational diabetes. These ...
Postprandial interval walking—effect on blood glucose in ...
This study demonstrated that 20 minutes of moderate intensity postprandial exercise can reduce glucose levels in women with GDM. Introduction. Gestational ...
Physical Activity and Exercise During Pregnancy and the ...
Studies have shown that exercise during pregnancy can lower glucose levels in women with GDM 42 43 or help prevent preeclampsia 44. Exercise has shown only a ...
Effects of Moderate-Intensity Aerobic Exercise on Blood ...
Moderate-intensity aerobic exercise can help improve blood glucose control and insulin use in patients with GDM.
Daily walking is effective for the management of pregnant ...
This study evaluated the usefulness of daily walking for gestational diabetes mellitus (GDM) management by analyzing the relationship between daily walking ...
Effects of resistance exercise on blood glucose level and ...
Researchs have shown that aerobic exercise has an effective effect on the blood glucose level, insulin dosage, and pregnancy outcome of patients with GDM.
9.
divisionofresearch.kaiserpermanente.org
divisionofresearch.kaiserpermanente.org/exercising-pregnancy-reduce-gestational-diabetes-risk/Exercising more in early pregnancy may reduce ...
It found that exercising at least 38 minutes per day lowered the risk of gestational diabetes by 2.1 cases per 100 women, and reduced risk of ...
10.
bmcpublichealth.biomedcentral.com
bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-025-24807-5Preventive effects of different types of exercises during ...
Effects of Moderate-Intensity aerobic exercise on blood glucose levels and pregnancy outcomes in patients with gestational diabetes mellitus ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.